These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
313 related articles for article (PubMed ID: 24959800)
1. Neuropsychiatric symptoms in patients with Alzheimer's disease with a vascular component. Bidzan M; Bidzan L; Pachalska M Ann Agric Environ Med; 2014; 21(2):412-5. PubMed ID: 24959800 [TBL] [Abstract][Full Text] [Related]
2. [Neurobehavioral manifestation in early period of Alzheimer disease and vascular dementia]. Bidzan M; Bidzan L Psychiatr Pol; 2014; 48(2):319-30. PubMed ID: 25016769 [TBL] [Abstract][Full Text] [Related]
3. Neuropsychiatric profiles of patients with Alzheimer's disease and vascular dementia in Taiwan. Hsieh CJ; Chang CC; Lin CC Int J Geriatr Psychiatry; 2009 Jun; 24(6):570-7. PubMed ID: 19051223 [TBL] [Abstract][Full Text] [Related]
4. The need for a consensus in the use of assessment tools for Alzheimer's disease: the Feasibility Study (assessment tools for dementia in Alzheimer Centres across Europe), a European Alzheimer's Disease Consortium's (EADC) survey. Paulino Ramirez Diaz S; Gil Gregório P; Manuel Ribera Casado J; Reynish E; Jean Ousset P; Vellas B; Salmon E Int J Geriatr Psychiatry; 2005 Aug; 20(8):744-8. PubMed ID: 16035121 [TBL] [Abstract][Full Text] [Related]
5. Long-term effects of rivastigmine treatment on neuropsychiatric and behavioral disturbances in nursing home residents with moderate to severe Alzheimer's disease: results of a 52-week open-label study. Aupperle PM; Koumaras B; Chen M; Rabinowicz A; Mirski D Curr Med Res Opin; 2004 Oct; 20(10):1605-12. PubMed ID: 15462693 [TBL] [Abstract][Full Text] [Related]
6. [Sleep disorders in the preclinical period of the Alzheimer's disease]. Bidzan L; Grabowski J; Dutczak B; Bidzan M Psychiatr Pol; 2011; 45(6):851-60. PubMed ID: 22335128 [TBL] [Abstract][Full Text] [Related]
7. [Vascular factors and the psychopathological picture in Alzheimer's disease]. Idzan LB; Bidzan M Psychiatr Pol; 2006; 40(5):823-31. PubMed ID: 17217228 [TBL] [Abstract][Full Text] [Related]
8. [Validity and reliability of the Japanese Version of the Neuropsychiatric Inventory-Nursing Home Version (NPI-NH)]. Shigenobu K; Hirono N; Tabushi K; Ikeda M Brain Nerve; 2008 Dec; 60(12):1463-9. PubMed ID: 19110758 [TBL] [Abstract][Full Text] [Related]
9. [Japanese version of the Neuropsychiatric Inventory--a scoring system for neuropsychiatric disturbance in dementia patients]. Hirono N; Mori E; Ikejiri Y; Imamura T; Shimomura T; Hashimoto M; Yamashita H; Ikeda M No To Shinkei; 1997 Mar; 49(3):266-71. PubMed ID: 9125732 [TBL] [Abstract][Full Text] [Related]
10. [Comparison of cognitive functions and neuropsychiatric symptoms between patients with Parkinson's disease dementia and Alzheimer's disease]. Tang Y; Ji XJ; Xing Y; Zuo XM; Zhou AH; Jia JP Zhonghua Yi Xue Za Zhi; 2013 Aug; 93(31):2459-62. PubMed ID: 24300264 [TBL] [Abstract][Full Text] [Related]
11. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice]. Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552 [TBL] [Abstract][Full Text] [Related]
12. [Vascular risk factors in demented elderly: analysis of Alzheimer Clinic materials]. Czyzewski K; Pfeffer A; Wasiak B; Łuczywek E; Gołebiowski M; Styczyńska M; Barcikowska M Neurol Neurochir Pol; 2001; 35(3):405-13. PubMed ID: 11732264 [TBL] [Abstract][Full Text] [Related]
13. Impact of cerebrovascular pathology on behavioural and neuropsychiatric symptoms in patients with Alzheimer's dementia: findings from a retrospective, naturalistic study. Klugman A; Marshall J; Tabet N Int J Clin Pract; 2009 Jul; 63(7):1024-30. PubMed ID: 19570120 [TBL] [Abstract][Full Text] [Related]
14. Pain in nursing home residents and correlation with neuropsychiatric disorders. Walid MS; Zaytseva N Pain Physician; 2009; 12(5):877-80. PubMed ID: 19787013 [TBL] [Abstract][Full Text] [Related]
15. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting. Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990 [TBL] [Abstract][Full Text] [Related]
16. Prevalence of neuropsychiatric symptoms in Alzheimer's disease: a cross-sectional descriptive study in Thailand. Charernboon T; Phanasathit M J Med Assoc Thai; 2014 May; 97(5):560-5. PubMed ID: 25065098 [TBL] [Abstract][Full Text] [Related]
17. Prevalence and severity of gait disorders in Alzheimer's and non-Alzheimer's dementias. Allan LM; Ballard CG; Burn DJ; Kenny RA J Am Geriatr Soc; 2005 Oct; 53(10):1681-7. PubMed ID: 16181166 [TBL] [Abstract][Full Text] [Related]
18. A study of the Alzheimer's Disease Assessment Scale-Cognitive (ADAS-Cog) in an Icelandic elderly population. Hannesdóttir K; Snaedal J Nord J Psychiatry; 2002; 56(3):201-6. PubMed ID: 12079572 [TBL] [Abstract][Full Text] [Related]
19. The neuropsychiatric inventory scores change across the mini mental state examination ranges in patients with Alzheimer's disease: a multicenter study in Turkey. Yener GG; Cogn Behav Neurol; 2009 Dec; 22(4):264-9. PubMed ID: 19996880 [TBL] [Abstract][Full Text] [Related]
20. Prevalence of neuropsychiatric symptoms in Alzheimer's disease and vascular dementia. Fernández-Martínez M; Castro J; Molano A; Zarranz JJ; Rodrigo RM; Ortega R Curr Alzheimer Res; 2008 Feb; 5(1):61-9. PubMed ID: 18288933 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]